Pictet Asset Management
HAE icon

Pictet Asset Management’s Haemonetics HAE Stock Holding History

Pictet Asset Management’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$500K Sell
6,662
-754
-10% -$48.4K ﹤0.01% 1509
2026
Q1 		$418K Buy
7,416
+610
+9% +$39.7K ﹤0.01% 1566
2025
Q4 		$546K Sell
6,806
-571
-8% -$38.4K ﹤0.01% 1396
2025
Q3 		$360K Hold
7,377
– – ﹤0.01% 1548
2025
Q2 		$550K Sell
7,377
-757
-9% -$50.1K ﹤0.01% 1317
2025
Q1 		$517K Buy
8,134
+1,171
+17% +$79.6K ﹤0.01% 1338
2024
Q4 		$544K Buy
6,963
+979
+16% +$78.6K ﹤0.01% 1329
2024
Q3 		$481K Sell
5,984
-357
-6% -$28.8K ﹤0.01% 1346
2024
Q2 		$525K Buy
6,341
+396
+7% +$34.8K ﹤0.01% 1262
2024
Q1 		$507K Buy
5,945
+199
+3% +$15.6K ﹤0.01% 1298
2023
Q4 		$491K Hold
5,746
– – ﹤0.01% 1285
2023
Q3 		$515K Buy
+5,746
New +$513K ﹤0.01% 1210

Other funds holding HAE

RRAM
River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
MMA
Mizuho Markets Americas New York $6.37B AUM 47.14% 1-Year Est. Return
IP
Isthmus Partners Madison, Wisconsin $1.03B AUM 22.86% 1-Year Est. Return
PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return
Retirement Systems of Alabama
Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return
SC
Skylands Capital Milwaukee, Wisconsin $814M AUM 32.37% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
EIP
Easterly Investment Partners Beverly, Massachusetts $1.97B AUM 25.87% 1-Year Est. Return

Pictet Asset Management's HAE Position: Q2 2026 in Review

Pictet Asset Management reduced its Haemonetics (HAE) stake by 10% in Q2 2026, selling an estimated $48.4K and leaving 6,662 shares worth $500K. The position accounts for ﹤0.01% of the portfolio, ranked #1509.

Pictet Asset Management first reported a position in HAE in Q3 2023 and has held it in 12 quarters since. The position peaked at $550K in Q2 2025. 87 funds tracked by Wall St. Rank hold HAE as of Q2 2026.

  • Pictet Asset Management held 6,662 shares of Haemonetics worth $500K as of Q2 2026.
  • Pictet Asset Management sold 754 Haemonetics shares in Q2 2026, an estimated $48.4K.
  • Haemonetics made up ﹤0.01% of Pictet Asset Management's portfolio in Q2 2026, its #1509 holding.
  • Pictet Asset Management first reported a position in Haemonetics in Q3 2023 and has held it in 12 quarters since.
  • Pictet Asset Management's Haemonetics position peaked at $550K in Q2 2025.
  • 87 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.

Based on Pictet Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.